Although studies have described that higher DANCR expression was positively correlated with diverse cancers [12, 13], the roles of the aberrant upregulation of DANCR in Taxol-resistant prostate cancers remain largely unknown. This evidence concerns the gene DANCR and prostate carcinoma.